Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K981729
    Manufacturer
    Date Cleared
    1999-01-28

    (258 days)

    Product Code
    Regulation Number
    866.3510
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    IS-RUBELLA IGG TEST SYSTEM

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Diamedix Is-Rubella IgG Test Kit is an Enzyme Immunoassay (EIA) for the qualitative and quantitative determination of IgG antibodies in human serum to aid in the assessment of the patient's immunological response to infection with rubellaand in the determination of the immune status of individuals, including females of child-bearing age. The evaluation of acute and convalescent sera can aid in the diagnosis of recent or current infection with rubella. These reagents can be used either manually or in conjunction with the MAGO® Plus Automated EIA Processor.

    Device Description

    The Is-Rubella IgG Test System is an enzyme-linked immunosorbent assay (ELISA) for the qualitative and quantitative detection of IgG to rubella in human serum. Partially purified rubella antigen is attached to a solid phase microtiter well. Diluted test sera are added to each well. If antibodies which recognize the rubella antigen are present in the patient sample they will bind to the antigen on the well. After incubation, the wells are washed to remove unbound antibody. An enzyme labeled anti-human immunoglobulin (conjugate) is added to each test well. If antibody is present the enzyme-linked antibody will bind to it. After incubation, the wells are washed to remove unbound conjugate. A substrate solution is then added to each well. If enzyme is present from the prior step, the reaction is stopped and the color intensity is measured photometrically producing an indirect measure of the specific antibody present in the patient sample.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and the study details for the Diamedix Is-Rubella IgG Test System, based on the provided text:

    Acceptance Criteria and Reported Device Performance

    The document does not explicitly state pre-defined "acceptance criteria" in terms of specific quantitative thresholds that the device must meet to be considered effective. Instead, it presents performance characteristics in comparison to existing marketed tests (predicate devices) and a CDC reference panel. The overall goal appears to be demonstrating substantial equivalence to these predicate devices.

    However, we can infer performance targets from the reported results, particularly overall agreement, sensitivity, and specificity. The data is presented as a comparison, implying that similar performance to established methods is the 'acceptance criteria.'

    MetricAcceptance Criteria (Implied from predicate performance/benchmark)Reported Device Performance (Range Across Sites/Methods)Study Section Where Found
    Relative Sensitivity (Qualitative)High agreement with predicate (e.g., >95%)93.3-100.0% (Site #1: 97.1%; Site #2: 100.0%; Site #3 Manual: 98.1%; Site #3 MAGO Plus: 99.5%)A. Comparison Testing
    Relative Specificity (Qualitative)High agreement with predicate (e.g., >95%)82.4-100.0% (Site #1: 100.0%; Site #2: 83.8%; Site #3 Manual: 100.0%; Site #3 MAGO Plus: 100.0%)A. Comparison Testing
    Overall Agreement (Qualitative)High agreement with predicate (e.g., >95%)92.2-99.6% (Site #1: 97.4%; Site #2: 96.3%; Site #3 Manual: 98.4%; Site #3 MAGO Plus: 99.6%)A. Comparison Testing
    Agreement with CDC Panel (Negative)100%100% (Manual & Automated)C. CDC Serum Panel Data
    Agreement with CDC Panel (Positive)High (e.g., >95%)97.6% (Manual & Automated)C. CDC Serum Panel Data
    Correlation (Manual vs. Automated)Strong positive linear correlation (r approaching 1)r = 0.9550B. Correlation of Manual and MAGO Plus Results
    Linearity (R-squared)High (e.g., >0.99)R-squared: 0.9933 (Manual), 0.9969 (MAGO Plus)C. Linearity
    Correlation to WHO Standard (R-squared)High (e.9, >0.98)R-squared: 0.9846D. Correlation to WHO Standard
    Lack of Cross-ReactivityNo cross-reactivity with common viral antibodies0 positive results for rubella IgG in samples positive for other virusesF. Cross-Reactivity Data
    Precision (CV%)Lower CV% preferred, especially for quantitative assays. Typically
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1